Chou Ann F, Scholle Sarah Hudson, Weisman Carol S, Bierman Arlene S, Correa-de-Araujo Rosaly, Mosca Lori
Department of Health Administration and Policy, College of Public Health and College of Medicine, University of Oklahoma, 801 NE 13th Street, Oklahoma City, OK 73120, USA.
Womens Health Issues. 2007 May-Jun;17(3):120-30. doi: 10.1016/j.whi.2007.03.002. Epub 2007 Apr 19.
Studies have shown that women with cardiovascular disease (CVD) are screened and treated less aggressively than men and are less likely to undergo cardiac procedures. Research in this area has primarily focused on the acute setting, and there are limited data on the ambulatory care setting, particularly among the commercially insured. To that end, the objective of this study is to determine if gender disparities in the quality of CVD care exist in commercial managed care populations.
Using a national sample of commercial health plans, we analyzed member-level data for 7 CVD quality indicators from the Healthcare Effectiveness Data and Information Set (HEDIS) collected in 2005. We used hierarchical generalized linear models to estimate these HEDIS measures as a function of gender, controlling for race/ethnicity, socioeconomic status, age, and plans' clustering effects.
Results showed that women were less likely than men to have low-density lipoprotein (LDL) cholesterol controlled at <100 mg/dL in those who have diabetes (odds ratio [OR], 0.81; 95% confidence interval [CI], 0.76-0.86) or a history of CVD (OR, 0.72; CI 95%, 0.64-0.82). The difference between men and women in meeting the LDL control measures was 5.74% among those with diabetes (44.3% vs. 38.5%) and 8.53% among those with a history of CVD (55.1% vs. 46.6%). However, women achieved higher performance than men in controlling blood pressure (OR, 1.12; 95% CI, 1.02-1.21), where the rate of women meeting this quality indicator exceeded that of men by 1.94% (70.8% for women vs. 68.9% for men).
Gender disparities in the management and outcomes of CVD exist among patients in commercial managed care plans despite similar access to care. Poor performance in LDL control was seen in both men and women, with a lower rate of control in women suggesting the possibility of less intensive cholesterol treatment in women. The differences in patterns of care demonstrate the need for interventions tailored to address gender disparities.
研究表明,患有心血管疾病(CVD)的女性在筛查和治疗方面不如男性积极,接受心脏手术的可能性也较小。该领域的研究主要集中在急性病方面,而关于门诊护理方面的数据有限,尤其是在商业保险人群中。为此,本研究的目的是确定在商业管理式医疗人群中,心血管疾病护理质量是否存在性别差异。
我们使用全国商业健康保险计划样本,分析了2005年收集的来自医疗保健效果数据和信息集(HEDIS)的7项心血管疾病质量指标的会员级数据。我们使用分层广义线性模型,将这些HEDIS指标估计为性别的函数,并控制种族/民族、社会经济地位、年龄和保险计划的聚类效应。
结果显示,在患有糖尿病(优势比[OR],0.81;95%置信区间[CI],0.76 - 0.86)或有心血管疾病病史(OR,0.72;95% CI,0.64 - 0.82)的人群中,女性低密度脂蛋白(LDL)胆固醇控制在<100 mg/dL的可能性低于男性。在患有糖尿病的人群中,男性和女性在达到LDL控制指标方面的差异为5.74%(44.3%对38.5%);在有心血管疾病病史的人群中,差异为8.53%(55.1%对46.6%)。然而,在控制血压方面,女性的表现优于男性(OR,1.12;95% CI,1.02 - 1.21),达到该质量指标的女性比例比男性高出1.94%(女性为70.8%,男性为68.9%)。
尽管商业管理式医疗计划中的患者获得医疗服务的机会相似,但在心血管疾病的管理和治疗结果方面存在性别差异。男性和女性在LDL控制方面表现不佳,女性的控制率较低,这表明女性可能接受的胆固醇治疗强度较低。护理模式的差异表明需要采取针对性别差异的干预措施。